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Abstract 
Heterotrimeric guanine nucleotide–binding protein (G protein) signaling links hundreds of G 
protein–coupled receptors (GPCRs) with four G protein signaling pathways. Two of these, 
one mediated by Gq and G11 (Gq/11) and the other by G12 and G13 (G12/13), are implicated in 
the force-dependent activation of transforming growth factor–β (TGFβ) in lung epithelial 
cells. Reduced TGFβ activation in alveolar cells leads to emphysema, whereas enhanced 
TGFβ activation promotes acute lung injury and idiopathic pulmonary fibrosis. Therefore, 
precise control of alveolar TGFβ activation is essential for alveolar homeostasis. Here, we 
investigated the involvement of the Gq/11and G12/13 pathways in epithelial cells in generating 
active TGFβ and regulating alveolar inflammation. Mice deficient in both Gαq and Gα11 
developed inflammation that was primarily caused by alternatively activated (M2-polarized) 
macrophages, enhanced matrix metalloprotease 12 (MMP12) production, and age-related 
alveolar airspace enlargement consistent with emphysema. Mice with impaired Gq/11 
signaling had reduced stretch-mediated generation of TGFβ by epithelial cells and enhanced 
macrophage MMP12 synthesis, but were protected from the effects of ventilator-induced lung 
injury. Furthermore, synthesis of the cytokine interleukin-33 (IL-33) was increased in these 
alveolar epithelial cells, resulting in the M2-type polarization of alveolar macrophages 
independently of the effect on TGFβ. Our results suggest that alveolar Gq/11 signaling 
maintains alveolar homeostasis, and likely independently increases TGFβ activation in 
response to mechanical stress of the epithelium and decreases epithelial IL-33 synthesis. 
Together, these findings suggest that disruption of Gq/11 signaling promotes inflammatory 
emphysema but protects against mechanically induced lung injury. 
 
Introduction 
Heterotrimeric guanine nucleotide–binding protein (G protein) signaling is a ubiquitous 
system that couples many hundreds of G protein–coupled receptors (GPCRs) to a diverse 
array of effector molecules. Despite the huge diversity of receptors and effectors, there are 
only four families of heterotrimeric G proteins: GS, Gi/Go, Gq/G11, and G12/G13. Two of 
these families (Gq/G11 and G12/G13) mediate activation of the RhoA signaling pathways (1, 
2). Work by our group and others identified that Gq/G11 and G12/G13 signaling to RhoA 
and Rho kinase in epithelial cells is central to the αvβ6 integrin–mediated activation of 
transforming growth factor–β (TGFβ) in vitro (3, 4). However, the importance of 
heterotrimeric G protein signaling pathways in the activation of TGFβ in the alveoli in vivo 
has not been described. 
 
TGFβ plays a central role in diverse physiological processes, including homeostasis, repair, 
and immunity. The essential role of TGFβ in maintaining alveolar homeostasis was 
demonstrated in mice with defective TGFβ signaling pathways. Mice deficient in Smad3 (5), 
a major intracellular signal transducer and transcriptional modulator of TGFβ signaling, or 
the epithelial TGFβ receptor subunit TGFβRII (6) develop age-related emphysema because 
of increased production of matrix metalloprotease-12 (MMP12) by alveolar macrophages. 
Furthermore, over-expression of TGFβ in the lung leads to pulmonary fibrosis (7), and 
increased TGFβ abundance is associated with the development of acute and ventilator-
associated lung injury (8, 9). Disruption of alveolar TGFβ signaling also leads to human 
disease. Mutations in TGFβ1 and its receptors, as well as reduced serum concentrations of 
TGFβ1 are associated with the development of chronic obstructive pulmonary disease 
(COPD) (10-12). Furthermore, increased TGFβ signaling in the alveoli is associated with 
conditions such as idiopathic pulmonary fibrosis (IPF) (13). Therefore, precise control of 
alveolar TGFβ activity is central to the homeostatic function of pulmonary alveoli. Activation 
of the latent TGFβ complex is the rate-limiting step in TGFβ biosynthesis, and it is mediated 
in cells in vitro by a number of distinct mechanisms, including physical changes such as low 
pH or oxidation, proteases (14-16), or through the direct physical interaction of the 
extracellular domain of integrins with the RGD-binding site in the latent TGFβ binding 
protein (17-19). Studies in mice suggest that in vivo, in development at least, most pulmonary 
TGFβ1 activation is through both the αvβ6 and αvβ8 integrins (20, 21). Furthermore, mice 
with no functional αvβ6 integrins develop MMP12-dependent, age-related emphysema (22), 
consistent with observations from mice with defective TGFβ signaling. 
 
To investigate the whether G protein signaling pathways were required to generate alveolar 
TGFβ and control alveolar homeostasis, mice were generated that were deficient in both Gαq 
and Gα11 (Gαq/Gα11) or in both Gα12 and Gα13 (Gα12/Gα13) surfactant protein C (SftpC)-
positive cells, restricting the defect in signaling predominantly to type II alveolar (ATII) 
epithelium. We showed that alveolar epithelial Gq/G11 signaling was required not only to 
promote stretch-mediated production of TGFβ by epithelial cells within the lungs, but also to 
suppress synthesis of the key epithelial alarmin interleukin-33 (IL-33) and inhibit the M2 
polarization of alveolar macrophages. Loss of signaling through this pathway leads to 
emphysematous changes in the lungs because of the disruption of epithelial cell–mediated 
suppression of macrophage activation and the resulting widespread alveolar destruction, but 
protected against stretch-mediated lung injury. 
 
Results 
Characterization of mice deficient in Gαq/Gα11 or Gα12/Gα13 in surfactant protein C–
positive epithelial cells 
To assess the role of the Gq/G11 and G12/G13 signaling pathways in alveolar epithelial cell 
function, two strains of mice were generated by Cre-loxP recombination. Mice heterozygous 
for the expression of Cre-recombinase under the control of the surfactant protein C promoter 
(SftpC+/-) were crossed with mice either constitutively deficient in the gene encoding Gα11 
(Gna11-/-) and carrying floxed alleles of the gene encoding Gαq (Gnaqfl/fl) (23) or 
constitutively deficient in the gene encoding Gα12 (Gna12-/-) and carrying floxed alleles of 
the gene encoding Gα13 (Gna13fl/fl) (24) to generate alveolar epithelial cell–specific, double 
knockout mice termed SftpC+/-;Gnaqfl/fl;Gna11-/- and SftpC+/-;Gna12-/-;Gna13fl/fl, respectively. 
SftpC+/-;Gnaqfl/fl;Gna11-/- progeny were born at the expected Mendelian ratios from regular 
matings of founder animals. In contrast, the litter sizes of mice in the SftpC+/-;Gna12-/-
;Gna13fl/fl colony were smaller and animals were not born at the expected Mendelian 
frequency (12.5% of each genotype), with only 6.8% of offspring being Cre-positive and 
carrying two null Gna12 alleles and two floxed Gna13 alleles. 
 
Gαq/Gα11 colony mice were genotyped by PCR analysis (fig. S1A). Cre-mediated deletion 
of Gnaq in the alveolar cells of SftpC+/-;Gnaqfl/fl;Gna11-/- mice was confirmed by a reduction 
in the abundances of Gαq protein (fig. S1B) and mRNA (fig. S1C) compared with those of 
alveolar type II (ATII) cells isolated from Cre-negative Gna11-/- control mice. 
Immunohistochemical analysis of Gαq proteins demonstrated that the signaling molecule was 
not detected in ATII cells from SftpC+/-;Gnaqfl/fl;Gna11-/- mice, but was detected in Cre-
negative Gna11-/- mice (fig. S1D). Gα12/Gα13 colony mice were genotyped by PCR analysis 
(fig. S1E), and the Cre-mediated deletion of Gna13 in the ATII cells of SftpC+/-;Gna12-/-
;Gna13fl/fl mice was confirmed by immunohistochemical analysis of Gα13 protein (fig. S1F) 
and real time reverse-transcriptase PCR (RT-PCR) analysis of the abundance of Gna13 
mRNA in ATII cells (fig. S1G). 
 
Gq/11-deficient mice have alveolar airspace enlargement and an obstructive lung defect 
Analysis of the lungs from SftpC+/-;Gnaqfl/fl;Gna11-/- mice (Fig. 1A) revealed that they were 
morphologically normal at two weeks of age, although by four weeks there were widespread 
inflammatory infiltrates and architectural distortion within the lungs. There was enhanced 
inflammation and localized disruption of the alveolar architecture at six weeks, and this was 
maximal at eight weeks of age. Mean linear intercept analysis confirmed that substantial 
increases in alveolar size were not detected in the SftpC+/-;Gnaqfl/fl;Gna11-/- mice until they 
were four weeks of age (Fig. 1B), and that these animals subsequently showed a progressive 
and age-related increase in the size of the alveoli up to eight weeks of age compared with 
age-matched Gna11-/- control mice. Although there was no further increase in mean linear 
intercept beyond eight weeks, alveolar size remained substantially greater in SftpC+/-
;Gnaqfl/fl;Gna11-/- mice than in Gna11-/- mice up to six months of age (Fig.1B). In contrast 
with that of SftpC+/-;Gnaqfl/fl;Gna11-/- mice, mean linear intercept analysis of lung sections 
from Cre-positive heterozygous Gαq/Gα11 colony mice and from SftpC+/-;Gna12-/-;Gna13fl/fl 
mice showed no evidence of increased alveolar airspace size (fig S2A) or inflammatory 
infiltrates (fig. S2, B to D). Even at the later time points of 12 and 24 weeks of age (fig. S2E), 
there was no evidence of inflammation or architectural distortion in the lungs of SftpC+/-
;Gna12-/-;Gna13fl/fl mice, suggesting that G12/G13 signaling does not play a role in the 
postnatal development of alveoli or in alveolar homeostasis. 
 
To confirm that the morphological changes had functional consequences, lung function was 
measured by invasive plethysmography at eight weeks of age. SftpC+/-;Gnaqfl/fl;Gna11-/- mice 
showed an obstructive defect as evidenced by a statistically significant reduction in the ratio 
of forced expiratory volume in the first 100 ms (FEV100) to forced vital capacity (FVC), that 
is, the FEV100/FVC (Fig. 1C). A reduction in the FEV100/FVC ratio is characteristic of the 
development of emphysema together with increased static lung volumes as reflected by 
statistically significantly increased total lung capacity (TLC) (fig. S3A) and functional 
residual capacity (FRC) (fig. S3B) when compared with Gna11-/- mice. There was no 
significant increase in residual volume (RV) detected in the SftpC+/-;Gnaqfl/fl;Gna11-/- mice 
(fig. S3C). Leukocytes isolated from the bronchoalveolar lavage fluid (BALF) of SftpC+/-
;Gnaqfl/fl;Gna11-/-  mice had substantially increased amounts of Mmp2 (Fig. 1D), Mmp9 (Fig. 
1E), and Mmp12 (Fig. 1F) mRNAs compared with those of Gna11-/- mice, as determined by 
real time RT-PCR analysis, which suggests a contributory role for these enzymes in the 
alveolar destruction observed in the SftpC+/-;Gnaqfl/fl;Gna11-/-  mice. 
 
Loss of alveolar epithelial Gq/11 signaling leads to decreased activation of TGFβ in the 
lung 
To determine whether TGFβ signaling pathways were disrupted by the loss of Gαq and Gα11 
from epithelial cells, we measured the total TGFβ1 concentrations in whole-lung 
homogenates and found them to be substantially decreased in SftpC+/-;Gnaqfl/fl;Gna11-/- mice 
compared to those in Gna11-/- control mice (Fig. 2A). Analysis of supernatants collected from 
cultured lung slices detected the release of active TGFβ from the Gna11-/- lung slices, but no 
active TGFβ1 was measured in the supernatants of SftpC+/-;Gnaqfl/fl;Gna11-/-  lung slices (Fig. 
2B). To examine the role of Gαq and Gα11 in TGFβ activation in response to a contraction 
stimulus, lung slices were incubated with methacholine, which activates Gq/G11 signaling 
through muscarinic receptors. There was no substantial increase in the amount of active 
TGFβ detected in the lung slice supernatants of either genotype (Fig. 2B); however, treatment 
of slices from Gna11-/- mice with methacholine led to increased amounts of phosphorylated 
Smad2 (pSmad2) protein in lung slice lysates, which was not observed in the treated slices 
from SftpC+/-;Gnaqfl/fl;Gna11-/- animals (Fig. 2C). 
 
To confirm that the reduction in total TGFβ generation observed was to the result of reduced 
alveolar TGFβ activation in vivo, BAL leukocytes were used as reporter cells for the 
activation of TGFβ in epithelial cells (Fig. 2D). Nuclear extracts of BAL leukocytes collected 
from SftpC+/-;Gnaqfl/fl;Gna11-/- mice had substantially less pSmad2 abundance than did the 
nuclear extracts of BAL leukocytes from Gna11-/- mice, thus confirming that the amount of 
active TGFβ produced by the lung epithelium was reduced in the SftpC+/-;Gnaqfl/fl;Gna11-/- 
mice (Fig. 2D). Furthermore, exogenous stimulation of BAL leukocytes from SftpC+/-
;Gnaqfl/fl;Gna11-/- mice with TGFβ for 1 hour stimulated a small, although statistically 
significant, increase in pSmad2 abundance, which was considerably blunted compared with 
that observed in cells from Gna11-/- mice (Fig. 2D). RT-PCR analysis of the expression of 
two TGFβ-responsive genes, Itgb6 (Fig. 2E) and Tsp1 (Fig. 2F) demonstrated that ATII cells 
from SftpC+/-;Gnaqfl/fl;Gna11-/- mice had statistically significantly lower amounts of both 
mRNAs than did cells from Gna11-/- littermate controls. 
 
Disruption of alveolar Gq/G11 signaling leads to aberrant alveolar macrophage 
responses 
To investigate the mechanism behind the reduced responsiveness of BAL leukocytes from 
SftpC+/-;Gnaqfl/fl;Gna11-/- mice to TGFβ (Fig 2D), we measured the abundances of the 
mRNAs encoding TGFβ receptor I (Tgfbr1) and II (Tgfbr2). Tgfbr1 mRNA abundance was 
substantially reduced in BAL macrophages from SftpC+/-;Gnaqfl/fl;Gna11-/- mice compared to 
that in cells from Gna11-/- littermate control mice (Fig. 3A). In contrast, the abundance of 
Tgfbr2 mRNA was increased in the cells isolated from SftpC+/-;Gnaqfl/fl;Gna11-/- mice, 
although this difference did not reach statistical significance (Fig. 3A). To determine whether 
TGFβR abundance in BAL macrophages was regulated by factors secreted into the alveolar 
compartment, crossover experiments were performed in which BAL macrophages from 
Gna11-/- mice or SftpC+/-;Gnaqfl/fl;Gna11-/- mice were cultured with BALF from either Gna11-
/- mice or SftpC+/-;Gnaqfl/fl;Gna11-/-mice and then Tgfbr mRNA abundances were assessed. 
Tgfbr mRNA abundance was measured in BAL macrophages from SftpC+/-;Gnaqfl/fl;Gna11-/- 
animals cultured in BALF from SftpC+/-;Gnaqfl/fl;Gna11-/- mice or Gna11-/- mice, and 
exposure of SftpC+/-;Gnaqfl/fl;Gna11-/- macrophages to BALF from Gna11-/- mice for 24 hours 
induced a statistically significant increase in macrophage Tgfbr1 expression, which was 
blocked by concomitant administration of an anti-TGFβ blocking antibody (Fig. 3B). 
Stimulation of BAL macrophages from SftpC+/-;Gnaqfl/fl;Gna11-/- mice with TGFβ induced a 
substantial increase in Tgfbr1 mRNA abundance, which confirms a role for TGFβ in 
regulating the expression of its own receptor (Fig. 3C). To assess the consequences of 
reduced alveolar TGFβ activation on BAL macrophages from SftpC+/-;Gnaqfl/fl;Gna11-/-mice, 
we measured Mmp12 mRNA abundance. Culturing alveolar macrophages, obtained from the 
BAL from Gna11-/- mice in BALF from the SftpC+/-;Gnaqfl/fl;Gna11-/-mice induced the 
expression of Mmp12 in these cells. This increase was markedly inhibited by co-stimulation 
with exogenous TGFβ (Fig. 3D) suggesting that the Gq/11-dependent generation of TGFβ 
from epithelial cells is required to suppress macrophage MMP12 production and prevent the 
development of emphysema. In contrast, co-administration of an anti-TGFβ blocking 
antibody led to a trend towards increased Mmp12 mRNA abundance (Fig 3E), but this was 
not statistically significant. 
 
Loss of Gq/G11 signaling leads to inflammatory cell recruitment and the M2 
polarization of alveolar macrophages 
A characteristic feature of SftpC+/-;Gnaqfl/fl;Gna11-/- mice was the appearance of enlarged and 
vacuolated cells within the alveolar airspaces (Fig. 4A), which stained positive for the 
macrophage marker F4/80 (Fig. 4B). SftpC+/-;Gnaqfl/fl;Gna11-/- mice had a 10-fold increase in 
the total numbers of leukocytes within the alveolar airspaces compared with Gna11-/-, Cre-
positive heterozygous littermate controls or SftpC+/-;Gna12-/-;Gna13fl/fl mice (Fig. 4C). 
Cytospin analysis of BALF from the SftpC+/-;Gnaqfl/fl;Gna11-/- animals confirmed the 
increased numbers of enlarged, vacuolated cells (Fig. 4D), which were not observed in the 
cytospins from any other genotype and were made up of approximately 50% of the cells 
within the BALF (Fig. 4E). Phenotypic analysis revealed a heterogeneous population of 
macrophages with widespread distribution of M2-like markers, including resistin-like 
molecule α (RELMα; M2a) and mannose receptor (M2a/c) together with a more restricted 
pattern of sphingosine kinase (Sphk1; M2b) positivity in the BAL cells isolated from SftpC+/-
;Gnaqfl/fl;Gna11-/- mice (Fig 4F). Quantification of the immunofluorescence staining 
confirmed the increased amounts of all three M2 macrophage markers. Although there was a 
statistically significant increase in the abundance of inducible nitric oxide synthase (iNOS) in 
the SftpC+/-;Gnaqfl/fl;Gna11-/- BAL cells, most of the enlarged macrophages did not contain 
iNOS, suggesting that they had an M2 phenotype (Fig. 4F). Further analysis also 
demonstrated that macrophages from SftpC+/-;Gnaqfl/fl;Gna11-/- animals contained 
significantly more IL-10 than did macrophages from Gna11-/- mice (Fig. 4G), which is 
consistent with their polarization to an M2 phenotype. 
 
Disruption of alveolar epithelial Gq/G11 signaling leads to increased IL-33 production 
To determine the effect of disrupting alveolar epithelial Gq/G11 and G12/G13 signaling on 
global gene networks, Affymetrix gene chip analysis was performed on mRNA isolated from 
alveolar epithelial cells from Gna11-/-, SftpC+/-;Gnaqfl/fl;Gna11-/-, Gna12-/-, and SftpC+/-
;Gna13fl/fl;Gna12-/- mice. Affymetrix analysis compared gene expression in SftpC+/-
;Gnaqfl/fl;Gna11-/- cells with that in four different comparator groups, namely: (i) Gna11-/- 
mice alone; (ii) SftpC+/-;Gna13fl/fl;Gna12-/- mice alone; (iii) Gna11-/- mice and Gna12-/- mice 
combined; and (iv) Gna11-/- mice, Gna12-/- mice, and SftpC+/-;Gna13fl/fl;Gna12-/- mice 
combined. Using the data obtained from all four contrasting genotypes we identified 304 
probes that mapped to 256 genes (see supplementary data file S1) that were differentially 
expressed in the SftpC+/-;Gnaqfl/fl;Gna11-/- epithelial cells regardless of the comparator group 
used. Hierarchical cluster analysis of the differentially expressed genes showed separation 
between epithelial cells from the SftpC+/-;Gnaqfl/fl;Gna11-/-mice and epithelial cells from mice 
of all other genotypes (Fig. 5A), reflecting the differences observed in the pulmonary 
phenotype. Ingenuity Pathway Analysis suggested increased activation of signal transducer 
and activator of transcription 6 (STAT6) pathways terminating in enhanced IL-33 production 
in the SftpC+/-;Gnaqfl/fl;Gna11-/- alveolar epithelial cells compared with that in alveolar 
epithelial cells from Gna11-/- control mice, which was confirmed by Western blotting analysis 
(Fig. 5B). 
 
Immunohistochemical analysis of lung tissue detected increased IL-33 abundance in the 
nuclei of ATII cells from SftpC+/-;Gnaqfl/fl;Gna11-/- mice compared with that in the nuclei of 
ATII cells from Gna11-/- mice (Fig. 5, C and D). Cytoplasmic IL-33 was present only in 
alveolar epithelial cells from SftpC+/-;Gnaqfl/fl;Gna11-/- mice (Fig. 5, C and D). Concentrations 
of IL-33 in lung homogenates from SftpC+/-;Gnaqfl/fl;Gna11-/- mice were statistically 
significantly greater than those in lung homogenates from Gna11-/- mice (Fig. 5E). In 
contrast, concentrations of the T helper 2 (TH2)-type cytokines IL-4, IL-10, and IL-13 were 
similar between SftpC+/-;Gnaqfl/fl;Gna11-/- mice and Gna11-/- mice (fig. S4, A to C). Although 
the amount of the soluble IL-33 receptor ST2 was not substantially increased in lung tissue 
homogenates (fig. S4D), it was markedly increased in the BALF from SftpC+/-
;Gnaqfl/fl;Gna11-/- mice compared with that in the BALF from Gna11-/- mice, suggesting that 
IL-33 was secreted into the extracellular compartment (Fig. 5F). The concentrations of IL-33 
in the lungs of mice deficient in Itgb6 (which encodes the β6 integrin subunit) were not 
substantially different from those in the lungs of wild-type mice (Fig. 5G), suggesting that 
αvβ6 integrin–mediated activation of TGFβ was not required to suppress IL-33 production. 
 
The increased IL-33 production from Gq/11-deficient epithelial cells promotes the 
polarization of alveolar macrophages to an M2 phenotype 
To assess the role of IL-33 in M2 macrophage polarization, alveolar macrophages from 
Gna11-/- mice were cultured in BALF from SftpC+/-;Gnaqfl/fl;Gna11-/- mice, which resulted in 
a substantial increase in Il10 mRNA abundance (Fig. 6A). Concomitant treatment with 
exogenous TGFβ had no effect on Il10 mRNA abundance; however, the induction of Il10 
mRNA expression was completely inhibited by an anti-IL-33 blocking antibody (Fig. 6A). 
Similarly, exposure of Gna11-/- macrophages to BALF from SftpC+/-;Gnaqfl/fl;Gna11-/- mice 
resulted in a trend towards increased Arginase 1 (Arg1; M2a/c) and Sphk1 mRNA 
abundances (characteristic of M2 macrophages), although these differences were not 
statistically significant (Fig. 6B). Neutralization of IL-33 in the BALF from SftpC+/-
;Gnaqfl/fl;Gna11-/- mice blocked the increase in Arg1 and Sphk1 mRNA abundances in the 
alveolar macrophages (Fig. 6B). Furthermore, culturing alveolar macrophages from Gna11-/- 
mice in the BALF from SftpC+/-;Gnaqfl/fl;Gna11-/- mice for 24 hours lead to the increased 
abundance of the M2a macrophage marker RELMα, as measured by immunofluorescence, 
which was substantially inhibited in the presence of an anti-IL-33 blocking antibody (Fig. 6, 
C and D). Together, these date suggest that the M2 macrophage polarization in the SftpC+/-
;Gnaqfl/fl;Gna11-/- mice is driven by the increased production of IL-33 by alveolar epithelial 
cells. 
 
Gq/11 signaling in alveolar epithelial cells transduces stretch-mediated generation of 
TGFβ in the lungs 
To assess the role of alveolar epithelial Gq/G11 signaling in stretch-mediated TGFβ 
generation, Gna11-/- mice and SftpC+/-;Gnaqfl/fl;Gna11-/- mice were exposed to high pressure 
ventilation to induce ventilator-induced lung injury (VILI). Mice of each genotype were 
ventilated for 60 min to a standardized plateau pressure (Gna11-/- mice: 37.93 ± 037 cm H2O; 
SftpC+/-;Gnaqfl/fl;Gna11-/- mice: 37.83 ± 038 cm H2O) that was designed to impart an 
equivalent degree of mechanical stress and stretch to each set of lungs. This period of high-
pressure ventilation (VT) was followed by 3 hours of non-injurious ventilation. Gna11-/- mice 
showed statistically significant increases in peak inspiratory pressure (Fig. 7A), plateau 
pressure (Fig. 7B), and lung elastance (Fig. 7C) after exposure to high VT, which is indicative 
of the development of lung injury. In contrast, SftpC+/-;Gnaqfl/fl;Gna11-/- mice were protected 
from the development of physiological responses associated with ventilator-induced lung 
injury (Fig. 7, A to C). There was no statistically significant difference in lung resistance 
between the two genotypes of mice (Fig. 7D). 
 
Protection from the development of ventilator-induced lung injury in SftpC+/-;Gnaqfl/fl;Gna11-
/- mice was linked to the inability of these animals to generate TGFβ1 in response to 
mechanical stretch (Fig. 7E). Lung TGFβ1 concentrations were substantially increased in 
Gna11-/- animals exposed to short-term, high-stretch ventilation compared with those in 
animals exposed to only non-injurious low ventilation pressures for 4 hours. These stretch-
induced increases in TGFβ1 were completely abrogated in SftpC+/-;Gnaqfl/fl;Gna11-/- mice. 
Although IL-33 concentrations were statistically significantly greater in the lungs of SftpC+/-
;Gnaqfl/fl;Gna11-/- mice than in the lungs of their Gna11-/- littermate controls, IL-33 
production in the lungs was not dependent on alveolar epithelial stretch (Fig. 7F), suggesting 
that Gq/G11 signaling has non-overlapping effects on the TGFβ and IL-33 signaling 
pathways. 
 
Discussion 
The aim of this study was to investigate the role of two key G protein signaling pathways, 
those mediated by Gq/G11 and G12/G13, in the regulation of alveolar epithelial homeostasis, 
and to understand the pathological consequences of disrupting these pathways within the 
alveoli. Because of the functional redundancy of closely related G proteins and the induction 
of compensatory processes, it was necessary to perform studies in animals in which pairs of 
G proteins were deleted. Embryonic lethality has been reported in both Gq/G11 (23) and 
G12/G13 (25) knockout animals; therefore, a cell-targeted approach was required in which 
pairs of G proteins were deleted only in SftpC-positive epithelial cells within the lung. 
Comparisons were made with Gna11-/- or Gna12-/- Cre-negative littermate control mice, 
which previously had no reported lung abnormalities. 
 
We did not find any phenotype associated with the alveolar deletion of both Gna12 and 
Gna13 with respect to lung development. Similarly, we did not find any phenotype associated 
with Gna11-/- animals, although we cannot exclude a role for these G proteins in response to 
lung injury. We did, however, show that deletion of both Gαq and Gα11 in SftpC-positive 
ATII cells led to a phenotype of impaired TGFβ signaling and enhanced IL-33 production. 
This resulted in M2 macrophage polarization and the increased expression of Mmp12 by 
macrophages, which resulted in changes within the lungs, including inflammation and 
alveolar airspace enlargement consistent with emphysema. Although we cannot completely 
exclude the possibility that the observed phenotype was primarily because of the alveolar 
deletion of Gnaq, we believe that this is unlikely for a number of reasons. First, most genetic 
models have not demonstrated any evidence of defects in the absence of Gαq alone. In the 
few cases in which Gαq deficiency promotes abnormalities, such as defective platelet 
activation (26) and the development of cerebellar ataxia (27), this is because Gα11 is not 
found in platelets (26) or is present at relatively low abundance in Purkinje cells (28). 
Second, these observations are consistent with biochemical data showing that GPCRs do not 
distinguish between Gαq and Gα11 (29-32) and that both G proteins regulate the same 
effectors (33, 34). Therefore, it is likely that the observed phenotype is the result of deletion 
of both the Gαq and Gα11 signaling molecules. 
 
We determined that impaired Gq/G11 signaling in alveolar epithelial cells led to two 
nonredundant, non-overlapping consequences in the alveoli. First, we observed reduced 
stretch-mediated TGFβ1 generation in the alveoli as measured by reduced TGFβ1 release in 
vivo, in addition to decreased amounts of active TGFβ and pSmad2, which were measured ex 
vivo in methacholine-treated lung slices from SftpC+/-;Gnaqfl/fl;Gna11-/- mice. This deficiency 
in TGFβ production in the alveoli ultimately resulted in altered macrophage functioning 
because of a reduction in Tgfbr1 expression and an increase in Mmp12 expression in alveolar 
macrophages. Second, we identified increased synthesis of IL-33 by alveolar epithelial cells, 
which promoted the polarization of alveolar macrophages towards an M2 phenotype in ex 
vivo experiments. These data confirm our previous in vitro findings that suggest that Gq/G11 
signaling is crucial for mediating the activation of TGFβ in alveolar epithelial cells (4), and 
highlight a hitherto unknown role for alveolar Gq/G11 signaling in suppressing IL-33 
production and maintaining alveolar macrophage homeostasis. It is likely that the Gq/G11-
dependent generation of TGFβ and suppression of IL-33 production is a fundamental 
pathway in the epithelium. Previous studies of mice deficient in Rac1 (a downstream effector 
of Gq/G11 signaling) specifically in airway epithelial cells demonstrated enhanced 
inflammatory responses, impaired TGFβ production, and exaggerated IL-33–dependent 
responses (35), with which our data are consistent. Moreover, the intestinal helminth 
Heligmosomoides polygyrus secretes proteins that induce TGFβ signaling (36) and inhibit IL-
33 (37), thus mimicking the effect of epithelial Gq/G11 signaling. 
 
Previous in vivo studies that have attenuated TGFβ signaling in the lung, either through 
whole-body deletion of Smad3 (5) or αvβ6 integrins (22, 38) or through epithelial cell–
specific deletion of TGFβRII (6), have shown mild pulmonary inflammation, epithelial 
airspace enlargement, and enhanced Mmp12 expression, consistent with our findings with the 
SftpC+/-;Gnaqfl/fl;Gna11-/- mice. However, the degree of inflammation and airspace 
destruction observed in the lungs of SftpC+/-;Gnaqfl/fl;Gna11-/- mice was considerably worse 
at an earlier stage of development than that reported in the previous studies. It is possible that 
the combination of increased expression of Mmp9 and Mmp12 within the BAL leukocytes of 
the SftpC+/-;Gnaqfl/fl;Gna11-/- mice may contribute to the exaggerated response seen in these 
animals, because both effects may play a role in the development of emphysema (22, 39). 
However, we believe that the severe phenotype most likely results from the combined effects 
of a failure of TGFβ activation on alveolar epithelial cells and an increase in their production 
of IL-33. IL-33 is associated with enhanced pulmonary inflammation and increased 
generation of ST2 and IL-10 (40) in addition to promoting the polarization of macrophages 
toward an alternatively activated (M2) state (41, 42). Increased epithelial IL-33 has also 
previously been linked to the development of COPD (43). 
 
These data demonstrate that SftpC+/-;Gnaqfl/fl;Gna11-/- mice have reduced amounts of TGFβ 
in their lungs which, in contrast with Gna11-/- mice, could not be increased in response to 
epithelial cell stretch after high-pressure ventilation in vivo or methacholine-induced 
contraction ex vivo. This is consistent with a failure of αvβ6 integrin–mediated activation of 
TGFβ, which requires force generation through RhoA-induced intracellular cytoskeletal 
reorganization (4, 44, 45). The phenotype of impaired αvβ6 integrin–mediated TGFβ 
activation is further supported by the reduced abundance of pSmad2 in alveolar macrophages 
and the reduced abundance of itgb6 mRNA in alveolar epithelial cells from SftpC+/-
;Gnaqfl/fl;Gna11-/- mice. Our previous findings suggested a critical role for Gαq in the 
regulation of αvβ6 integrin–mediated TGFβ activation independently of the abundance of αvβ6 
(4). However, TGFβ signaling increases the epithelial cell abundance of αvβ6 integrin by 
inducing itgb6 expression (46), which has led to the proposal of a TGFβ–αvβ6 integrin 
positive feed-forward loop (47). These data support this hypothesis, because sustained 
reduction of alveolar TGFβ activation in the SftpC+/-;Gnaqfl/fl;Gna11-/- mice led to reduced 
itgb6 expression in alveolar epithelial cells. 
 
Itgb6-/- mice are protected from the development of ventilator-induced lung injury (9), and 
our data demonstrate that SftpC+/-;Gnaqfl/fl;Gna11-/- mice are also protected from the 
deleterious effects of high-pressure ventilation, suggesting that Gq/11 signaling pathways are 
crucial for epithelial mechanotransduced signals that promote TGFβ activation. Furthermore, 
we observed that airspace enlargement in the SftpC+/-;Gnaqfl/fl;Gna11-/- mice developed 
postnatally, when spontaneous ventilation began, and was not apparent until the mice were 
four weeks of age. Therefore, we propose the hypothesis that spontaneous ventilation leads to 
cyclical alveolar stretch and the release of GPCR ligands that act through the Gq/G11 
pathway to promote alveolar TGFβ activation, suppress macrophage Mmp12 expression, and 
prevent the subsequent development of emphysema. However, further evidence is required to 
determine whether the stretch-induced production of TGFβ is directly linked to TGFβ 
activation by the αvβ6 integrin. 
 
We suggest that Gq/G11 signaling has non-overlapping effects on TGFβ activation and IL-33 
production. Although previous studies have suggested that IL-33 is a mechanically stimulated 
cytokine (48), we found no evidence that IL-33 production in the lungs was regulated by 
exposure to epithelial cell stretch. Therefore, it is likely that the enhanced IL-33 generation 
observed in the SftpC+/-;Gnaqfl/fl;Gna11-/- mice was driven by transcriptional signals rather 
than by mechanotransduction. TGFβ limits the production of IL-33 by macrophages (49); 
therefore, it is possible that the observed increase in IL-33 abundance in the SftpC+/-
;Gnaqfl/fl;Gna11-/- mice was a result of reduced TGFβ activity in the alveoli. However, we do 
not favor this hypothesis because, in contrast to the findings in the SftpC+/-;Gnaqfl/fl;Gna11-/- 
mice, we did not observe any change in IL-33 concentrations in the lungs of Itgb6-/- mice. 
 
In summary, our findings suggest that Gq/G11 signaling is required for two non-overlapping 
signaling pathways: the mechanotransduced generation of TGFβ and the transcriptional 
suppression of IL-33, both of which appear to be essential for the maintenance of alveolar 
macrophage homeostasis. Enhanced IL-33 production promotes the polarization of the 
alveolar macrophages to an M2 phenotype, whereas the failure of epithelial cells to generate 
TGFβ led to impaired Tgfbr1 expression in alveolar macrophages and the loss of TGFβ–
mediated suppression of MMP12 production by macrophages. Loss of the homeostatic 
control of alveolar macrophages results in widespread alveolar destruction and airspace 
enlargement associated with the development of emphysema. These data confirm the central 
role of Gq/G11 signaling in stretch-mediated alveolar TGFβ generation in vivo, reveal a 
hitherto unknown role for Gq/G11 signaling in the regulation of IL-33 by epithelial cells, and 
highlight a molecular pathway that is required to prevent ventilation-associated alveolar 
disease. 
 
Material and Methods 
Study design 
All animal experiments were designed to test a specific hypothesis or objective, with data 
being recorded and reported in accordance with the guidelines from the Fund for The 
Replacement of Animals in Medical Experiments (FRAME) and Animal Research: Reporting 
of In Vivo Experiments (ARRIVE). Phenotyping experiments were performed blind to 
genotype to minimize bias and with a factorial design to minimize confounding variables. 
Animals were assigned a six-digit identity code at weaning and were genotyped before 
analysis, but data collection was performed by researchers blinded to genotype. Initial studies 
were performed to establish the baseline phenotype of the mice and the variability of 
observed biochemical, morphological, and physiological parameters. For ventilator-induced 
lung injury and lung function experiments, mice were assigned to experimental groups based 
on genotype; however, experimental procedures, data collection, and analysis were 
performed by an investigator blinded to the allocation sequence and genotype. Studies were 
powered to detect a 1 standard deviation difference in endpoints using a power calculation 
assuming an 80% power at the 5% significance level, resulting in group sizes of 5 to 8 mice 
per group based on initial phenotyping data. Sample sizes were pre-determined for in vitro 
studies with isolated primary cells, including RNA analysis and gene array studies and based 
on large expected effect sizes required three to six mice of each genotype. 
 
Experimental animals 
Mice were housed under specific pathogen–free conditions, and all animal experiments were 
performed in accordance with the U.K. Animals (Scientific Procedures) Act 1986 and 
approved by the Animal Welfare and Ethical Review Committee at the University of 
Nottingham. The generation of floxed alleles of the genes encoding Gαq (Gnaq) and Gα13 
(Gna13) and of the null alleles for the genes encoding Gα11 (Gna11) and Gα12 (Gna12) has 
been described previously (23, 24). Mice constitutively deficient in Gna11 and containing 
floxed alleles of Gnaq or mice constitutively deficient in Gna12 and containing floxed alleles 
of Gna13 were crossed with mice expressing Cre recombinase under the control of the 
Surfactant Protein C promoter (SftpC-Cre) obtained from Brigid Hogan, Duke University 
(50). Mice were genotyped from DNA isolated from ear notch biopsies by polymerase chain 
reaction (PCR) analysis with allele-specific primers (table S1) and analyzed by 
electrophoresis on ethidium bromide–stained agarose gels as previously described (23, 24). 
The genetic background of the mice was predominantly C57BL6 (at least a sixth-generation 
backcross for Gαq/Gα11 and Gα12/Gα13 mice and at least fourth-generation backcross for 
SftpC-Cre mice). 
 
Antibodies 
Anti-mouse Gαq (Clone E17, sc-393, Santa Cruz Biotechnology, UK) and anti-IL-33 (Clone 
Nessy-1, ab54385, Abcam, UK) antibodies were used for Western blotting analysis. The 
following antibodies for immunohistochemistry or immunofluorescence staining were 
purchased from Abcam: anti-Sphk1 (ab71700), anti-mouse iNos (ab15323), anti-mouse 
RELMα (ab39626), anti-mouse IL-10 (ab9969), anti-mouse Gnaq (ab128060), and anti-
Gα13 (Clone EPR5436). Anti-mouse CD206 (Mannose Receptor) was obtained from 
Serotec, UK (MCA225). Anti-mouse IL-33 (AF3626) and anti-TGFβ-1,2,3 blocking 
antibody (clone 1D11) were purchased from R&D systems, UK. Anti-IL-33 (Bondy-1-1) 
blocking antibody was from Caltag Medsystems Ltd, UK. Biotinylated or Dylight488- and 
Dylight649-labelled secondary antibodies were purchased from VectorLabs and Jackson 
ImmunoResearch, respectively. Horseradish peroxidase (HRP)-conjugated secondary 
antibodies for Western blotting analysis were obtained from Dako, UK. 
 
Quantitative morphometry and mean linear intercept 
Mice were terminally anaesthetized with Euthatal (Merial Animal Health, UK) and the lungs 
and trachea were exposed. The lungs were perfused with phosphate-buffered saline (PBS) 
containing heparin (40 U/ml) through the left ventricle to remove all of the blood before the 
trachea was cannulated. Lungs were insufflated in situ with 10% neutral-buffered formalin at 
a constant pressure of 20 cm H2O, removed, and paraffin-embedded for the preparation of 
histological sections. Lung morphology was assessed in hematoxylin and eosin–stained 5-µm 
tissue sections. For each set of lungs, eight random fields were photographed across all lobes 
with a Nikon Eclipse 90i microscope at 10x magnification and NIS Elements Software v3.2. 
Images were overlaid with a 100-µm grid, and the mean linear intercept [defined as the linear 
sum of the lengths, in µm, of all lines in all frames counted divided by the number of 
intercepts (defined as an alveolar septa intersecting with a counting line)] was calculated with 
a method adapted from Dunnill (51). 
 
Lung function measurements by forced pulmonary maneuvers 
Eight-week-old mice were anesthetized with an intraperitoneal injection of ketamine (75 
mg/kg) and medetomidine hydrochloride (1 mg/kg) to maintain spontaneous breathing under 
anesthesia. Mice were tracheostomized, placed in a body plethysmograph, and connected to a 
computer-controlled ventilator (Forced pulmonary maneuver system; Buxco Research 
Systems, USA). An average breathing frequency of 120 breaths/min was imposed on the 
anesthetized animal by pressure-controlled ventilation until a regular breathing pattern and 
complete expiration at each breathing cycle were obtained. To measure functional residual 
capacity (FRC), ventilation was stopped at the end of expiration through the immediate 
closure of a valve located proximally to the endotracheal tube. Pressure changes at the mouth 
and in the bodybox after spontaneous breathing maneuvers against a closed valve were 
recorded to calculate the FRC (Boyle’s law). To measure the total lung capacity (TLC), 
residual volume (RV), inspiratory capacity (IC), and vital capacity (VC), the quasistatic 
pressure volume maneuver was performed. In this maneuver, the lungs are inflated to a 
standard pressure of +30 cm H2O, which was followed by a slow exhalation until a negative 
pressure of -30 cmH2O was reached. The quasi-static compliance was defined as the 
volume:pressure ratio at 50% of the expiration (Cchord50). For the fast flow volume 
maneuver, lungs were first inflated to +30 cm H2O (TLC) and immediately afterwards 
connected to a highly negative pressure to enforce expiration until the RV reached –30 cm 
H2O. Forced expiratory flows (PEF and FEF), times of expiration and inspiration (Te, Ti), 
and forced expiratory volumes (forced expiratory volume at 100 and 200 ms, FEV100 and 
FEV200, respectively) were recorded during this maneuver. Suboptimal maneuvers were 
rejected, and for each test in every single mouse at least three acceptable maneuvers were 
conducted to obtain a reliable mean for all numeric parameters. 
 
Ventilator-induced lung injury 
Mice were anesthetized (80 mg/kg ketamine:8 mg/kg xylazine) and surgically instrumented 
for ventilation as described in detail previously (52) by an experimenter blinded to genotype. 
In brief, animals were tracheostomized and connected to a custom-made 
ventilator/pulmonary function testing system. The left carotid artery was cannulated to enable 
continual monitoring of arterial blood pressure, removal of samples for blood gas analysis at 
predetermined intervals, and infusion of fluids [heparin (10 U/ml) in 0.9% NaCl, 0.3 
ml/hour]. During surgery and the subsequent stabilization period, mice were ventilated with a 
noninjurious strategy [8 to 9 ml/kg tidal volume (VT), 3 cm H2O positive end expiratory 
pressure (PEEP), 120 breaths per minute] using 100% O2. Lung volume history was 
standardized by sustained inflation, and baseline respiratory mechanics were evaluated by the 
end-inflation occlusion technique. After baseline measurements were made, VT was increased 
to produce stretch-induced lung injury. Specifically, ventilation was standardized with a 
plateau pressure of 37.5 to 38.5 cm H2O, which was designed to ensure that mice of different 
genotypes were exposed to an equivalent degree of mechanical stress to stretch the lungs. 
Additionally, PEEP was set to zero, respiratory rate was 80 breaths per minute, and inspired 
gas was changed to 96% O2/4% CO2 to prevent hypocapnia. Animals were ventilated with 
this constant tidal volume for 60 min or until airway plateau pressure had increased by 15%, 
whichever occurred first. Ventilation was then returned to match the baseline “pre-stretch” 
strategy, and maintained for a further 3 hours. Sustained inflation maneuvers were performed 
every 30 min during this “non-injurious” ventilation period to reduce the development of 
atelectasis. Anesthesia was maintained by bolus intraperitoneal administration of 
ketamine:xylazine (40 mg/kg:4 mg/kg) every 20 to 25 min. Animals were terminated by 
overdose of anesthetic followed by exsanguination. The lungs were lavaged with 750 µl of 
ice-cold PBS containing phosphatase inhibitor cocktail (Calbiochem), and the recovered fluid 
was centrifuged at 210g for 5 min at 4°C. Aliquots of supernatant and the lavage cell pellet 
were frozen at -80°C. After lavage, the chest wall was opened and the right lung was tied off 
at the hilum, removed, and snap-frozen in liquid N2. Finally, the left lung was inflated with 
4% paraformaldehyde at 20 cm H2O before being embedded in paraffin for histological 
analysis. 
 
Precision-cut lung slices 
Mice were terminally anaesthetized as described earlier, exsanguinated, and then had their 
lungs and trachea exposed. The lungs were perfused with PBS containing heparin (200 U/ml) 
through the left ventricle to remove all of the blood. The trachea was cannulated and the 
lungs were filled with 1.2 ml of 1% low-melting point agarose pre-warmed to 42°C, which 
was followed by 0.3 ml of air. The lungs were cooled by covering them with ice-cold PBS to 
enable the agarose to set, carefully removed, and the lobes were dissected. Lung slices of 
150-µm thickness were prepared from each lung lobe with a VT1200S Vibratome (Leica). 
Lung slices (2 per well) were cultured overnight in serum-free DMEM containing penicillin 
and streptomycin before being stimulated. To induce contraction of the lung slices, they were 
repeatedly stimulated for 10 min with 100 µM methacholine at one-hour intervals for 8 hours. 
After they were stimulated, the lung slices were washed in PBS and homogenized in protein 
lysis buffer [20 mM Tris-HCl (pH 7.4), 137 nM NaCl, 2 nM EDTA, 25 mM β-
glycerophosphate, 1 nM Na3VO4, 1% Triton X-100, 10% glycerol]. This buffer was 
supplemented with leupeptin, phenylmethylsulfonyl fluoride (PMSF), protease inhibitor 
(protease inhibitor mixture, Roche Applied Science), dithiothreitol (DTT), and phosphatase 
inhibitor (PhosStop, Roche Applied Science) . 
 
Western blotting 
The amounts of Gαq or IL-33 in whole-cell extracts of ATII cells were determined by 
Western blotting analysis. Protein samples (30 µg per lane) were subjected to electrophoresis 
on a 10% SDS-polyacrylamide gel and blotted onto a polyvinylidene fluoride (PVDF) 
membrane. After blocking for 1 hour (in TBS, 5% nonfat milk, 0.1% Tween 20), the 
membrane was incubated either overnight at 4°C with monoclonal anti-Gαq antibody in 
blocking buffer or for 48 hours with anti-IL-33 antibody (Nessy-1). After being washed [with 
PBS (pH 7.4), 0.3% Tween-20] the membrane was incubated at room temperature in 
blocking buffer with the appropriate HRP-conjugated secondary antibody for 1 or 2 hours for 
the detection of Gαq or IL-33, respectively. The membrane was incubated with Enhanced 
Chemiluminescence (ECL) Western blotting detection reagent and visualized by exposure to 
Hyperfilm-ECL. To quantify the differential production of IL-33 in the alveolar epithelial 
cells, densitometry was performed with Adobe Photoshop CC2014 software and the mean 
pixel densities were calculated. Densitometry data are presented as the ratio of IL-33 
abundance to that of GAPDH in cells independently isolated from three mice per group. 
 
RNA isolation and quantitative RT-PCR 
Total RNA was extracted from lung samples, purified ATII cells, and BAL cells by 
homogenization in Trizol B (Invitrogen) and was processed according to the manufacturer’s 
instructions. Samples were reverse-transcribed into complementary DNA (cDNA) with 
Moloney murine leukemia virus reverse transcriptase (for BAL cell pellets; Promega, UK) or 
Superscript II reverse transcriptase (for lung samples and ATII cells; Invitrogen, UK). The 
cDNA was subjected to quantitative RT-PCR analysis with gene-specific primers (table S1). 
Amplification was performed with an MXPro3000 (Stratagene, UK) with KapaSybr FastTaq 
(Anachem, UK) on the following program: initial denaturation at 95°C for 3 min followed by 
40 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 10 s. Amplification of a single DNA 
product was confirmed by melting curve analysis. Data were analyzed relative to the 
abundances of the housekeeping genes hypoxanthine phosphoribosyltransferase 1 (Hprt) (for 
BAL samples) or glucuronidase beta (Gusb) (for whole-lung and ATII samples) and 
expressed as the fold-change in mRNA abundance using the ∆∆Ct equation as described 
previously (53). 
 
Bronchoalveolar lavage and cytospin analysis 
Animals were terminally anaesthetized as described earlier, their tracheae were cannulated, 
and their lungs were washed with eight sequential 0.5-ml aliquots of cold PBS or PBS 
containing 1x phosphatase inhibitor solution (ActivMotif, UK). Aliquots were pooled and 
centrifuged, and the cell pellets were resuspended in PBS or PBS containing 1x phosphatase 
inhibitor solution (ActivMotif) for the analysis of pSmad2 and macrophage culture 
experiments. Cells were counted with a Sceptre 2.0 automated cell counter (Millipore, UK) 
and cell concentrates were cytospun onto glass slides and stained with Diff-Quick (Dade 
Diagnostics). Cell subsets were counted under ×40 objective magnification (200 cells per 
slide). Designation of alveolar macrophages as “normal” or “enlarged” was made visually 
based on cell size. The enlarged macrophages observed only in SftpC+/-;Gnaqfl/fl;Gna11-/-  
mice were identified after cytospin analysis by their increased cytoplasmic surface area when 
compared with alveolar macrophages from Gna11-/-, Gna12-/-, or SftpC+/-;Gna12-/-;Gna13fl/fl 
animals. 
 
Culture of BAL cells 
BAL cells were collected into serum-free Dulbecco’s Modified Eagle Medium (DMEM, 
Lonza. UK) containing glutamine, penicillin, and streptomycin and pelleted by centrifugation 
at 150g for 5 min at 4°C. BAL fluid (BALF) was collected, and BAL cells were pooled from  
Gna11-/- mice (n = 10 to 24 mice) and SftpC+/-;Gnaqfl/fl;Gna11-/- mice (n = 3 to 5). For 
crossover experiments in which the effect of secreted factors in BALF on gene expression 
were examined, 2.5 x 105 BAL cells from Gna11-/- mice or SftpC+/-;Gnaqfl/fl;Gna11-/- mice 
were resuspended in 1 ml of the appropriate BALF and then were plated into 12-well plates 
for RNA endpoint analysis or in 250 μl of BALF and then were plated into 8-well chamber 
slides for immunofluorescent staining. Cells were incubated with BALF for 24 hours at 37°C, 
non-adherent cells were removed by washing, and the adherent macrophages were lysed by 
the addition of Trizol B before RNA was isolated or were fixed in ice-cold 100% methanol 
for 10 min before immunofluorescent staining was performed. For cytokine stimulation or 
blocking experiments, serum-free DMEM or BALF was mixed with TGFβ (2 ng/ml), anti-
TGFβ antibody (5 µg/ml, 1D11), or anti-IL-33 antibody (1.5 µg/ml, Bondy-1-1) and 
incubated with BAL cells in culture for 24 hours. 
 
Immunostaining and image analysis 
Formalin-fixed lung tissue sections (5-µm thickness) were de-paraffinized and re-hydrated 
before antigen retrieval by being microwaved in 10 mM citric acid buffer (pH 6.0). 
Endogenous peroxidase activity in the sections was blocked with methanol containing 3% 
H2O2 for 15 min at room temperature. Nonspecific binding was blocked with 5% normal 
serum before the sections were incubated overnight with primary antibody at 4°C, which was 
followed by a 30- to 60-min incubation with an appropriately labeled secondary antibody at 
room temperature. All sections were visualized with DAB and counterstained with 
hematoxylin and mounted in DPX (Sigma-Aldrich, UK) for immunohistochemical analysis 
or were counterstained with DAPI (Invitrogen, UK) for 5 min and mounted in Prolong Gold 
Antifade (Invitrogen) for immunofluorescence analysis. To stain isolated alveolar 
macrophages, methanol-fixed cells were permeabilized with 0.1% triton X-100 for 10 min 
before being blocked in 5% normal serum, incubated overnight with primary antibody at 4°C, 
and then incubated for 30 to 60 min with an appropriately fluorescently labeled secondary 
antibody at room temperature. All antibody incubations were performed in staining buffer 
containing PBS, 5% serum, and 0.1% BSA. Slides were washed in PBS (Sigma-Aldrich). 
Images were captured with a Nikon 90i (for immunohistochemistry) or a Nikon Ti confocal 
microscope (for immunofluorescence) with NIS-Elements Software v3.2. To quantify the 
staining of isolated alveolar macrophages, individual cells were identified with NIS-Elements 
Software v3.2, and the total numbers of pixels for both antibody-stained and negative control 
cells were calculated. Pixel counts were determined in 40 to 100 individual cells from images 
captured in 5 to 20 randomly selected fields of view. The average number of pixels per cell in 
the unstained sections (negative control) were subtracted from the values calculated for 
antibody-stained sections to eliminate autofluorescence, and the data were presented as the 
number of pixels/cell. 
 
Isolation of type II alveolar epithelial cells 
Mice were terminally anaesthetized as described earlier, exsanguinated, and had their lungs 
and trachea exposed. The lungs were perfused with PBS containing heparin (200 U/ml) 
through the left ventricle to remove all of the blood. The trachea was cannulated and 
bronchoalveolar lavage was performed with eight sequential 0.5-ml aliquots of cold PBS to 
remove leukocytes. The lungs were filled with 1 ml Dispase (BD Pharmingen, UK) and 
allowed to collapse naturally before the instillation of 0.5 ml of 1% low melting point agarose 
(Promega) pre-warmed to 42°C. The lungs were then covered in ice for 2 min to enable the 
agarose to set before they were removed. The lungs were incubated at room temperature for 
45 min in 2 ml of Dispase and then washed briefly in ice-cold PBS before being transferred 
to petri dishes containing DMEM with 10% FCS, glutamine, and DNase 1(100 U/ml, Sigma). 
Lung tissue was carefully separated from the large airways and blood vessels before the cell 
suspension was dissociated. The crude cell suspension was sequentially filtered through 70- 
and 40-µm tissue sieves (BD) and then plated into plastic petri dishes coated with mouse IgG 
(1.5 mg IgG/plate). Nonadherent cells were collected after a 1-hour incubation at 37°C and 
were pelleted by centrifugation at 150g for 5 min. Contaminating leukocytes were removed 
by negative sorting with magnetic beads labeled with sheep anti-rat CD16/32 and CD45 
antibodies (Dynabeads, Dynal) for 1 hour at 4°C according to the manufacturer’s 
instructions. The remaining cells were resuspended in Bronchial Epithelial Growth Medium 
(BEGM; Lonza) without hydrocortisone and containing keratinocyte growth factor (10 
µg/ml, R&D Systems) and the purity of the ATII cell suspension was assessed by modified 
Papanicolaou staining of cell cytospins as previously described (54). The cells were plated 
onto collagen-coated, 24-well plates and ATII cells were grown to confluence. Cell purity 
was routinely >75%, with the major contaminating cells being fibroblasts. For experiments in 
which ATII cells were to be used for mRNA analysis, an additional purification step was 
added after the completion of the standard protocol in which epithelial cells in the cell 
suspension were enriched by positive sorting with sheep anti-rat magnetic beads labeled with 
an anti-E-cadherin antibody (Dynabeads, Dynal). After washing to remove the bead-free 
cells, the mixture of beads and ATII cells was immediately mixed with Trizol B reagent. 
 
ELISA/Luminex analysis 
Total TGFβ1 concentrations in murine lung homogenates were measured after acid-activation 
of samples with a murine TGFβ1 Quantikine ELISA kit (R&D Systems). Concentrations of 
active TGFβ secreted into lung slice supernatants were also determined with this ELISA kit, 
but without acid activation. The concentrations of soluble ST2 were measured in lung 
homogenates and BALF with a mouse ST2/IL-1 R4 Quantikine ELISA Kit (R&D Systems), 
whereas the concentrations of IL-33, IL-4, IL-10, and IL-13 were assessed with a customized 
mouse Magnetic Luminex Screening Assay (R&D Systems). Additional IL-33 analysis was 
performed with a mouse IL-33 ELISA kit (R&D Systems). All assays were performed 
according to the manufacturers’ instructions. 
 
Measurement of pSmad2 by ELISA 
Nuclear protein was prepared from BAL cells with a Nuclear Extract kit (ActivMotif) 
according to the manufacturer’s protocol. To analyze lung slices, total protein extracts were 
generated according to the manufacturer’s instructions (Cell Signalling Technologies, UK). 
The amounts of pSmad2 were measured in 10 µg of nuclear protein (BAL cells) or 10 µg of 
total protein (lung slices) with a solid-phase Pathscan PhosphoSmad2 (Ser465/467) sandwich 
ELISA kit (Cell Signalling Technologies, UK) according to the manufacturer’s instructions. 
 
Microarray analysis 
Total RNA was assessed quantitatively on a Nanodrop and qualitatively (RIN>7) by 
Bioanalyser (Agilent, UK). After the quantity and quality of RNA were assessed, 10 ng of 
total RNA was used to prepare microarray hybridization probes with Epistem’s RNAamp 
RNA amplification kits (Epistem, Manchester, UK). After fragmentation the biotinylated 
cRNA was hybridized to Genechip Murine MOE430 2.0 microarrays (Epistem). After 
hybridization, the microarrays were washed and scanned with Genechip Scanner 7G. 
Microarray data were background-corrected, Log2-transformed, and normalized with Robust 
Multi-array Average (RMA), followed by quantile normalization, and the RMA data from all 
of the arrays that passed quality control were analyzed with Partek Genomics Suite version 
6.5. Principle Component Analysis (PCA) was used to interrogate the effects of all of the 
tracked and recorded experimental technical factors (dates, yields, randomization order, etc.) 
on overall cohort data structure. Multivariate analysis of variance (ANOVA) was applied 
within Partek GS software for each pairwise comparison of groups using the Method of 
Moments. To further rank or prioritize genes that might be useful as candidate biomarkers, 
the degree of change in RNA abundance, or fold change, was used to select genes that 
differed in expression statistically significantly by one-way ANOVA (unadjusted P value of 
< 0.05) between compared groups and also exhibited a two-fold or greater change in 
expression. Further selection was performed by establishing overlaps between treatment 
groups. Further investigation of biological relevance was performed with Ingenuity IPA 
software. 
 
Statistical analysis 
All statistical analyses were performed with GraphPad Prism 6 software. Data were assessed 
for normality. Where differences between two groups were measured, the pooled mean 
values were compared with unpaired t tests. Comparisons between more than two groups 
were made by one-way ANOVA with Bonferroni or Dunn-Šidák multiple testing corrections 
applied to post-hoc, pairwise comparisons. Comparisons between groups over multiple time 
points were made by repeated measures ANOVA. Corrected P values < 0.05 were considered 
to be statistically significant. 
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Fig. S1 Characterization of alveolar epithelial cell–specific, G protein–deficient mouse 
colonies. 
Fig. S2 Histological analysis of littermate control mice. 
Fig. S3. Loss of epithelial Gαq/Gα11 signaling leads to altered lung function. 
Fig. S4 Effect of the deficiency in epithelial Gq/11 signaling on the concentrations of TH2 
cytokines and ST2 in the lung. 
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Table S2. Sequences of RT-PCR primers. 
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Fig. 1. Age-related morphological changes in the lungs of mice with homozygous 
deficiency in Gαq and Gα11 in alveolar epithelial cells. (A) Hematoxylin and eosin (H&E) 
staining of lung sections of SftpC+/-;Gnaqfl/fl;Gna11-/- mice at 2 to 24 weeks of age. Images 
are representative of three to ten mice/genotype. (B) Mean linear intercept analysis of 
airspace size in Gna11-/- mice (hatched bars) and SftpC+/-;Gnaqfl/fl;Gna11-/- mice (solid bars). 
Data are means ± SEM of three to ten mice/group. (C) FEV100/FVC was measured by 
invasive plethysmography of the indicated mice at 8 weeks of age. Data are means ± SEM of 
six mice/group. (D to F) The relative abundances of Mmp2 mRNA (D), Mmp9 mRNA (E), 
and Mmp12 mRNA (F) in BAL leukocytes from 6- to 8-week-old Gna11-/- (n = 3) and 
SftpC+/-;Gnaqfl/fl;Gna11-/- (n = 6) mice were determined by  RT-PCR analysis. *P < 0.05; **P 
< 0.01; ***P < 0.001 ; ****P < 0.0001 by one-way ANOVA with Bonferroni corrected post-
hoc comparisons (B) or by unpaired t test (C to F). Scale bars, 100 μm. 
 
Fig. 2. Decreased TGFβ activation after disruption of the Gq/G11 signaling pathway in 
alveolar epithelial cells. (A) Total TGFβ concentrations in lung homogenates from the 
indicated mice were measured by ELISA Data are from 10 mice/group and means are 
represented by horizontal bars. Each symbol represents an individual mouse. (B) 
Concentrations of spontaneously active TGFβ in supernatants from lung slices of the 
indicated mice that were left unstimulated or were stimulated by repeated administration of 
100 µM methacholine. Data are means ± SEM of three mice/group. (C) Lung slices from the 
indicated mice were left untreated or were stimulated repeatedly with 100 µM methacholine. 
The amounts of pSmad2 in the lung slices were measured by ELISA. Data are means ± SEM 
of four mice/group. (D) BAL cells from the indicated mice were cultured in the presence or 
absence of TGFβ (2 ng/ml) for 1 hour before the concentrations of pSmad2 in the cells were 
determined. Data are means ± SEM of four mice/group. (E and F) The relative abundances of 
Itgb6 mRNA (E) and Tsp1 mRNA (F) in ATII cells from Gna11-/- mice (n = 3) and SftpC+/-
;Gnaqfl/fl;Gna11-/- mice (n = 3) were determined by RT-PCR analysis. The abundances of the 
indicated mRNAs were normalized to that of Gusb mRNA. Data are means ± SEM. *P < 
0.05; **P < 0.01; ***P < 0.001 when analyzed by unpaired t test (A, E, and F) or one-way 
ANOVA with Dunn-Šidák corrected post-hoc comparisons (B to D). 
 
Fig. 3. Aberrant responses in alveolar macrophages from SftpC+/-;Gnaqfl/fl;Gna11-/- mice. 
(A) The relative abundances of Tgfbr1 and Tgfbr2 mRNAs in BAL leukocytes from Gna11-/- 
and SftpC+/-;Gnaqfl/fl;Gna11-/- mice were determined by RT-PCR analysis. Data are means ± 
SEM of six mice per group. (B) The relative abundance of Tgfbr1 mRNA in alveolar 
macrophages from SftpC+/-;Gnaqfl/fl;Gna11-/- mice cultured for 24 hours in BALF from 
SftpC+/-;Gnaqfl/fl;Gna11-/- mice or from Gna11-/- mice in the presence or absence of an anti-
TGFβ antibody (α-TGFβ, 5 µg/ml). Data are means ± SEM and combined from three 
independent experiments with cells, BALF, or both pooled from 10 to 24 Gna11-/- mice per 
experiment or three to five SftpC+/-;Gnaqfl/fl;Gna11-/- mice per experiment. (C) The relative 
abundances of Tgfbr1 and Tgfbr2 mRNA in alveolar macrophages from SftpC+/-
;Gnaqfl/fl;Gna11-/- mice that were left unstimulated or were stimulated with TGFβ (2 ng/ml) 
for 8 hours were determined by RT-PCR. Data are means ± SEM of six mice per group. (D 
and E) The relative abundances of Mmp12 mRNA in alveolar macrophages isolated from 
Gna11-/- mice and cultured for 24 hours in BALF from Gna11-/- mice or SftpC+/-
;Gnaqfl/fl;Gna11-/- mice in the presence or absence of (D) TGFβ (2 ng/ml) or (E) anti-TGFβ 
antibody (5 µg/ml) were determined by RT-PCR. Data are combined from four independent 
experiments with cells, BALF, or both pooled from 10 to 24 Gna11-/- mice per experiment or 
three to five SftpC+/-;Gnaqfl/fl;Gna11-/- mice per experiment. The abundances of the indicated 
mRNAs were normalized to that of Hprt mRNA. Data are means ± SEM. *P < 0.05; **P < 
0.01; ***P < 0.001 when analyzed by unpaired t test (A) or one-way ANOVA with Dunn-
Šidák corrected post-hoc comparisons (B to D). 
 
Fig. 4. Accumulation of M2 macrophages in the lungs of mice with Gαq/Gα11-deficient 
alveolar epithelial cells. (A) High-power magnified image of enlarged and vacuolated cells 
(marked with arrows) in the alveoli of SftpC+/-;Gnaqfl/fl;Gna11-/-mice. Images are 
representative of three experiments. (B) Immunofluorescent staining of F4/80-positive cells 
(marked with arrows) in the lungs of SftpC+/-;Gnaqfl/fl;Gna11-/- mice. Images are 
representative of three experiments. (C) Total cell counts in BALF isolated from the 
indicated mice. (D) Cytospin analysis of BAL leukocyte populations isolated from the 
indicated mice and stained with Diff-Quik. (E) Analysis of alveolar macrophage morphology. 
The percentages of normal and enlarged macrophages in the BALF of the indicated mice 
were calculated. (F and G) Immunofluorescence staining (left) and quantification of M2 
markers (right; number of pixels/cell) in BAL cells from Gna11-/- and SftpC+/-
;Gnaqfl/fl;Gna11-/- mice for (F) RELMα, mannose receptor, Sphk1, and iNOS and (G) IL-10. 
Data in (C) and (E) are means ± SEM of three to ten mice per genotype. Data in (F) and (G) 
are means + SEM of the pixel counts/cell from 30 to 80 individual cells pooled from two 
independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 when 
analyzed by one-way ANOVA with Bonferroni corrected post-hoc comparisons (C) or by 
unpaired t test (E). All experiments were performed with 6-week-old mice. Scale bars, 20 
µm. 
 
Fig. 5. Increased alveolar IL-33 production in the absence of Gq/11 signaling. (A) 
Hierarchical cluster analysis of differentially expressed genes in epithelial cells from SftpC+/-
;Gnaqfl/fl;Gna11-/-, Gna11-/-, Gna12-/-, and SftpC+/-;Gna13fl/fl;Gna12-/- mice (n = 3 
mice/genotype). (B) Top: Alveolar epithelial cells from the indicated mice were analyzed by 
Western blotting with antibodies against the indicated proteins. Bottom: Densitometric 
analysis of the relative abundance of IL-33 protein normalized to that of GAPDH. Data are 
means ± SEM of three mice/genotype. (C and D) Low-power (C) and high-power (D) 
magnified images of immunohistochemical staining for IL-33 in the lungs of Gna11-/- and 
SftpC+/-;Gnaqfl/fl/Gna11-/- mice. Images are representative of three mice/genotype. (E) The 
amounts of IL-33 in lung homogenates from Gna11-/- and SftpC+/-;Gnaqfl/fl;Gna11-/- mice 
were determined by ELISA. Data are from 11 mice/genotype and means are presented by 
horizontal bars. (F) ST2 concentrations in BALF from Gna11-/- mice and SftpC+/-
;Gnaqfl/fl/Gna11-/- mice were determined by ELISA Data are from 8 mice/genotype and 
means are presented by horizontal bars. (G) The concentrations of IL-33 in lung homogenates 
from Itgb6-/- mice and their wild-type (WT) littermate controls were determined by ELISA. 
Data are from 5 or 6 mice/genotype and means are presented by horizontal bars. *P < 0.05; 
**P < 0.01; ***P < 0.001 by unpaired t test. Scale bars, 20 µm (C) and 10 µm (D). 
 
Fig 6. Regulation of alveolar macrophage M2 phenotype by IL-33. (A and B) The relative 
abundances of Il10 (A) and Arg1 and Sphk1 (B) mRNAs in alveolar macrophages that were 
isolated from SftpC+/-;Gnaqfl/fl;Gna11-/- mice and cultured for 24 hours in BALF from either 
Gna11-/- mice or SftpC+/-;Gnaqfl/fl;Gna11-/- mice in the presence or absence of TGFβ (2 
pg/ml) or anti–IL-33 blocking antibody (1.5 µg/ml). Data are combined from three 
independent experiments with cells pooled from 10 to 24 Gna11-/- mice and 3 to 5 SftpC+/-
;Gnaqfl/fl;Gna11-/- mice per experiment. (C and D) Immunofluorescence analysis (C) and 
quantification (D) of RELMα abundance in alveolar macrophages isolated from Gna11-/- 
mice and cultured for 24 hours in BALF from SftpC+/-;Gnaqfl/fl;Gna11-/- mice in the presence 
or absence of anti-IL-33 blocking antibody (1.5 µg/ml). Data are combined from two 
independent experiments with cells pooled from 10 to 24 Gna11-/- mice and BALF isolated 
from 3 to 5 SftpC+/-;Gnaqfl/fl;Gna11-/- mice/experiment. Quantification was performed on 40 
to 100 cells per treatment group in images captured from 5 to 20 fields of view. *P < 0.05; 
****P < 0.0001 by one-way ANOVA with Dunn-Šidák corrected post-hoc comparisons (A) 
or by unpaired t test (D). Scale bars, 20 µm. 
 
Fig. 7. Gq/11-dependent signaling pathways regulate stretch-mediated TGFβ 
production in the lungs. (A and B) Changes in peak inspiratory pressure (A) and plateau 
pressure (B) during the high-stretch (1 hour) and normal (low) ventilation periods (3 hours) in 
Gna11-/- and SftpC+/-;Gnaqfl/fl;Gna11-/- mice. (C and D) Effects of high stretch for 1 hour on 
lung elastance (C) and resistance (D) in the indicated mice. (E and F) Concentrations of 
TGFβ (E) and IL-33 (F) in the lungs of the indicated mice exposed to normal ventilation 
alone (4 hours) or high stretch for 1 hour followed by 3 hours of normal ventilation. 
Statistical analysis was performed by repeated measured ANOVA (A to D) or by one-way 
ANOVA with Dunn-Šidák corrected post-hoc comparisons (E and F). ****P < 0.0001. Data 
are means ± SEM (A to D) or calculated mean values (E and F) from four to nine mice/group. 







